Skip to content
lsd.com

Nebraska

Psychedelic trials in Nebraska

9 registered trials has a study site in Nebraska, and 1 is recruiting now.

9
Trials with a site here
1
Recruiting
4
Facilities

Open now

Recruiting in this state

TrialStatusPhaseSubstanceSites
Safety and Tolerability Trial of Psilocybin in Healthy Older AdultsNCT07516405 · University of Colorado, DenverRecruitingPhase 1psilocybin6

Facilities

Where the research happens in Nebraska

FacilityCityTrials
University of Nebraska Medical CenterOmaha2
Alivation Research, LLC.Lincoln2
VA Nebraska Western Iowa Health Care SystemOmaha1
Clinical Site 125Lincoln1

Stay told

When a trial opens in Nebraska

Research alerts

Get a notification when a trial for trials in Nebraska starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

All trials

Every trial with a Nebraska site

TrialStatusPhaseSubstanceSites
Safety and Tolerability Trial of Psilocybin in Healthy Older AdultsNCT07516405 · University of Colorado, DenverRecruitingPhase 1psilocybin6
Efficacy, Safety, and Tolerability of COMP360 in Participants With TRDNCT05624268 · COMPASS PathwaysCompletedPhase 3psilocybin40
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRDNCT05711940 · COMPASS PathwaysActive, not recruitingPhase 3psilocybin116
Psilocybin for Major Depressive Disorder (MDD)NCT06308653 · Usona InstituteActive, not recruitingPhase 3psilocybin29
A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant DepressionNCT02417064 · Janssen Research & Development, LLCCompletedPhase 3ketamine90
A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant DepressionNCT02493868 · Janssen Research & Development, LLCCompletedPhase 3ketamine155
A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant DepressionNCT02782104 · Janssen Research & Development, LLCCompletedPhase 3ketamine173
A Study of CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO StudyNCT04103892 · Clexio Biosciences Ltd.CompletedPhase 2ketamine46
Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal CancersNCT05220046 · University of NebraskaCompletedPhase 1psilocybin1

Site locations from ClinicalTrials.gov API v2, data build 2026-08-25.

Elsewhere

Other states